Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Guys - watch the bleeding presentation; listen to the recent interviews Alasdair gave; actually read & digest the RNS. The story here is BIG. VERY BIG. It's an absolutely pleasure listening to what Alasdair has to say. AVCT are making more new business 'movements' over the next 1 month than most AIM companies do in a lifetime. A CEO would not say we are fully funded for this year and 2021 if a placing was even remotely on the horizon. He would be linched. I really hope the MM's have finished now because I really can't afford to buy anymore more cheap shares. But we do ALL need to hold firm. The MM's can't play their games if investors / holders show resilience. The games are now obvious, MMs and others have been outed. We can now move onto a better day tomorrow, Friday and into next week. In AVCT I trust, and so should you. Best Regards to Rich Ken, Myles and others who hold and are in this for today, tomorrow and £10 a share. Signed Chartmychart.com
Strange ?
He’ll be filling his boots at these levels!
I am sorry but many on here are a bunch of wet lettuces ! Do you need your hand holding by Myles to take **** too ?
DYOR ! ... Myles and Rich Ken provide comfort to all (thanks lads) but c’mon they shouldn’t have to be posting every 1 hour just in case you decide to lose your bottle !
Ever thought that perhaps they , like the sensible ones here, might be adding through these lows !
If you are too nervous then ‘get off the pot’ !
Strong & calm. In Alan we trust !!
As I’ve said before I had the money I would be adding today. I have added from 90p all the way up to £1.98 so annoying that I can’t be adding more. My last top up was yesterday at £1.71. I would love an RNS, absolutely love one !
People should spend less time reading these boards being influenced by others too easily and actually read the RNS, listen to the last few interviews Alasdair has given and watch the company presentation. This is one of the very very few companies listed on AIM that is progressing world class opportunities on MULTIPLE fronts. There is no comparison between AVCT and any of the other COVID stocks. The next few RNSs are big yes but if you actually do as I say and watch, read and listen to what has been said already you really have nothing to be concerned with. Anyway if things weren’t going to plan, we’d have heard by now. The RNS’s will arrive this month and there will be several, whether that’s today or tomorrow, this week or next week who knows but they will land and they will be massive. Huge believer. All things in place.
Trump to announce new testing system today, has already said this will be pregnancy style POC tests - Cytiva is a US firm and I believe most likely to be providing this. I think there’s a reasonable chance his rollout plan is going to involve Cytiva / Avacta !
BBC News states yesterday that testing needs to be quick & confirm whether a person has the virus now - so an Antigen test is the only way they can do this. Avacta are the only ones doing this in the UK.
An announcement from either Government or from Avacta could land at any time. DYOR watch this space !
RAPID and testing to confirm whether the population might HAVE the virus - this is Antigen testing & only Avacta can provide this in the UK (as far as I know)....
The following is a direct quote from BBC website:
“Testing capacity has been ramped up significantly in recent weeks. As of 30 May, 115,725 tests were carried out.
The bulk were community swab tests for people concerned about symptoms and wanting to know if they have the virus.
Although rates of the infection have decreased substantially with lockdown, the virus has not disappeared from society.
People can still catch it and experts believe 8,000 a day in England currently are.
As lockdown eases, a new system called test and trace is being used to help keep the virus under control - identifying possible outbreaks.
Having enough tests on offer will be vital, as well as getting RAPID results back so people can be informed if they might HAVE the virus and therefore need to stay at home to stop the spread.
Widespread testing forms a central part of the government's strategy to control the virus, as it aims to ease blanket lockdown in favour of more targeted measures.”
RAPID and might HAVE the virus - this is Antigen testing & only Avacta can provide this in the UK (as far as I know)....
It’s a super time for a UK company to excel. Unless the test from abroad is substantially cheaper and substantially ‘better’ I can’t see there being much of a problem. As I said earlier today the biggest thing for me is that people including leaders of countries not just within the UK but all over the world are quickly recognising that a very quick & easy test (saliva and that anyone can do) is the way forward. Within the U.K. there is only Avacta offering this. If Trump decides that’s the way America is going, Boris (his pal) will follow suite. I would be very surprised if he didn’t. Quick & easy is the key and providing our test is better than 90% specificity I think a share price valuation of £3-£5 in the next 6-8 weeks is clear, obvious and easy achievable. Hold onto your shares; buy on any dips or if like me and you’re already ‘all in’ just HOLD and enjoy the sun !
If the US accept that pregnancy style testing is the way forward then his excellent news for Avacta shareholders IMO. I honestly don’t think it matters whether there’s a company in the US doing the same pregnancy style antigen test. In fact this makes it easier to convince the market that this is the right way of doing things. What is important is that our test works & is approved and if they are accepting in the US that pregnancy style antigen testing is the way forward then our shares will absolutely fly. This is a GLOBAL market. It is absolute fantasy to ever think we would would be the only company doing this or trying to. The key is that we are very close to news & providing we have the best test from a company in the U.K. then we are home & dry. This seems highly realistic and we have an established route to market. I am very optimistic and you all should be too.
Everyone should relax. The next news WILL be worth waiting for. We dropped 5% today and have dropped 15% from the absolute high of £2.15, and we’ve not had an RNS yet. We are days away from a monumental moment for Investors. When the RNS lands, and it definitely will next week, the price will rocket. The test being created by Avacta and its partners will enable an individual with the COVID-19 infection, WHETHER THEY HAVE SYMPTOMS OR NOT, to be identified BEFORE antibodies have been generated by the body. Just think on that for a second. WHETHER SHOWING SIGNS OR NOT, that’s amazing. Given this test will be saliva based (so very easy to do), it could be used in airports, offices, factories, schools, sports grounds, supermarkets, shopping centres, Nando’s ?? etc and in the home environment, providing a RESULT WITHIN MINUTES and with NO REQUIREMENT for medical supervision. It is potentially GROUND-BREAKING and a major step forward in the fight against COVID-19. As investors surely this news is worth waiting for ? Watching the price drop is annoying yes but take the pain and give some back, BUY on the drop, any amount you can, or HOLD, because you’ll wish you had !!
Been involved from the sidelines for a while now. Naturally disappointed the price has dropped but best way of coping is to buy into it the drop. MM's don't tend to shake a bad share. You can sell more than you can buy. Significantly more, nearly always. This means smaller holders are nervous and bigger buyers are happy taking shares. The price will be taken through the £1.80s shortly (and beyond). Actually read the RNS's & Watch Alasdair Smith and what he says. I have no doubts that this price will rise beyond levels we have already seen within the next few trading days. MM's don't tend to shake a bad share !!
Listen and smile gang. Listen and smile !!!
https://www.*************.net/avacta-group-antigen-distribution-agreement-and-potential-treatment-for-covid-19-interview/